Recently, it was shown that tonsillar CD94+ ILCs could kill human leukemia cells, and IL-12 could induce this phenotype in non-cytotoxic fraction by upregulating cytolytic machinery and several NK cell-expressed molecules, including CD94 and Eomes (22). This evidence concerns the gene KLRD1 and leukemia.